Status | Study |
Completed |
Study Name: PR-018: An Open-Label, Safety Extension of Study PR-011 Condition: Cystic Fibrosis Exocrine Pancreatic Insufficiency Date: 2010-05-25 Interventions: Drug: EUR-1008 (APT-1008) EUR-1008 (APT-1008) (Zenpep® [pancrelipase] 3,000 lipase units delayed re |
Completed |
Study Name: A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age Condition: Cystic Fibrosis Exocrine Pancreatic Insufficiency Date: 2010-03-31 Interventions: Drug: EUR-1008 (APT-1008) EUR- |
Completed |
Study Name: Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency Condition: Pancreatic Insufficiency Date: 2009-11-11 Interventions: Dietary Supplement: Norzyme - Bergamo |
Completed |
Study Name: Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency Condition: Cystic Fibrosis Exocrine Pancreatic Insufficiency Date: 2009-09-21 Interventions: Drug: EUR-1008 (APT-1008) EUR-1008 (APT-1008) Microtabs contained in a capsule will be administered oral |
Completed |
Study Name: A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI) Condition: Chronic Pancreatitis Exocrine Pancreatic Insufficiency Date: 2008-11-10 Interventions: Drug: Placebo Placebo matching |
Completed |
Study Name: Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency Condition: Cystic Fibrosis Exocrine Pancreatic Insufficiency Date: 2008-08-26 Interventions: Drug: rhBSSL oral suspension, 170 mg BSSL, 3 times daily for 5-6 days |
Completed |
Study Name: Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis Condition: Pancreatic Insufficiency Date: 2008-06-26 Interventions: Drug: Pancreatin Pancreatin wi |
Terminated |
Study Name: Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis Condition: Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis Date: 2008-02-22 Interventions: Drug: Placebo Placebo |
Completed |
Study Name: An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI) Condition: Exocrine Pancreatic Insufficiency Date: 2007-11-14 Interventions: Drug: VIOKASE 16 The VIOKASE 16 is to be taken as 3 tablets with the perfusion procedure. |
Completed |
Study Name: Creon After Pancreatic Surgery Condition: Pancreatic Insufficiency Date: 2007-09-25 Interventions: Drug: Creon 3 capsules Creon w |